ask="9.95"
ask_size="100"
average_daily_volume="165582"
bid="4.15"
bid_size="100"
book_value="7.07"
change="-0.04"
change_from_200_day_moving_average="6.68"
change_from_50_day_moving_average="3.01"
change_from_52_week_high="-4.34"
change_From_52_week_low="3.36"
change_in_percent="-0.42%"
close="9.46"
dividend_pay_date="6/27/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.47"
ebitda="-15.57M"
eps_estimate_current_year="-3.65"
eps_estimate_next_quarter="-0.75"
eps_estimate_next_year="-2.10"
ex_dividend_date="6/28/2013"
float_shares="7983000"
high="9.56"
high_52_weeks="13.80"
last_trade_date="1/23/2017"
last_trade_price="9.46"
last_trade_size="281"
last_trade_time="4:00pm"
low="9.34"
low_52_weeks="6.10"
market_capitalization="99.94M"
moving_average_200_day="2.78"
moving_average_50_day="6.45"
name="Novelion Therapeutics Inc. "
notes="N/A"
one_year_target_price="13.50"
open="9.53"
pe_ratio="N/A"
peg_ratio="0.17"
percent_change_from_200_day_moving_average="+240.08%"
percent_change_from_50_day_moving_average="+46.77%"
percent_change_from_52_week_high="-31.45%"
percent_change_from_52_week_low="+55.08%"
previous_close="9.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.34"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="10565000"
short_ratio="13.10"
stock_exchange="NMS"
symbol="NVLN"
volume="128737"
weeks_range_52="6.10 - 13.80"
